The First Case of Obstructing Bronchial Aspergillosis Caused by Aspergillus Sydowi
Liao Wanqing,Wen Hai,Chen Yuchong,Li Qian,Yao Zhilong,Wu Jianghua,Xu Hong,Xu Deqian
DOI: https://doi.org/10.1016/j.ijid.2003.10.003
IF: 12.073
2004-01-01
International Journal of Infectious Diseases
Abstract:A 51-year-old man was diagnosed with pulmonary cancer in the right upper lobe and underwent a right upper lobectomy and radiotherapy with two cycles of chemotherapy. Six months later he showed signs of a non-productive cough and dyspnea. Laboratory findings showed the ratio of CD4 to CD8 T lymphocytes had decreased to 0.51 (normal range 0.8–1.5). During a fiberoptic bronchoscopy his right main bronchus was found to be obstructed by neoplasia covered with white pseudomembrane. There were abundant hyphae and spores, but six transbronchial biopsies revealed no malignant cells. The fungus was identified as Aspergillus sydowi (Bain and Sait/Thom and Church). A CAT scan of the lung showed pulmonary atelectasis of the upper right field but no inflammation in pulmonary parenchyma. A diagnosis of obstructing bronchial aspergillosis caused by Aspergillus sydowi was made. A bronchial stent was inserted and the bronchi lavaged with amphotericin B at a dose of 5 mg on two occasions. Three weeks later he received amphotericin B intravenously at a dose of 50 mg/d for 10 days, then 100 mg/d of liposomal amphotericin B (Amphotec®) for 30 days. Because of the persistence of the symptoms, he was given itraconazole intravenously at a dose of 400 mg/d for 14 days, transbronchial debridement, 0.125% amphotericin B lavage and fog inhalation, followed by two weeks of oral itraconazole (400 mg/d). The fungus reduced and the symptoms improved. Aspergillus sydowi is found throughout the world. Animal experiments have shown that it could cause hepatic or gastric cancer. We have not found any cases of obstructing bronchial aspergillosis caused by A. sydowi in Medline data (from 1990–2001). Our case was confirmed as obstructing bronchial aspergillosis caused by A. sydowi by fiberoptic bronchoscopy, direct microscopic examination, culture and histopathology. Obstructing bronchial aspergillosis is non-invasive, and the fungus was not found in the bronchial biopsy sample. It commonly infects AIDS patients and patients receiving lung transplantations. Aspergillus spp. develop in bronchi, causing inflammation and exudation, forming a pseudomembrane that is a combination of exudate, necrotic epithelial cells, hyphae and spores, manifesting with coughing, dyspnea, and segmental or lobular atelectasis.1.Routsi C. Platsouka E. Prekates A. et al.Aspergillus bronchitis causing atelectasis and acute respiratory failure in an immunocompromised patient.Infection. 2001; 29: 243-244Crossref PubMed Scopus (20) Google Scholar, 2.Ikeue T. Nishiyama H. Yokomise H. et al.A case of non-invasive pulmonary aspergillosis that rapidly deteriorated.Nihon Kokyuki Gakkai Zasshi. 2001; 39: 582-586PubMed Google Scholar, 3.Daly P. Kavanagh K. Pulmonary aspergillosis: clinical presentation, diagnosis and therapy.Br. J. Biomed. Sci. 2001; 58: 197-205PubMed Google Scholar The patient in this case had undergone a right upper lobectomy, radiotherapy and chemotherapy and was infected by A. sydowi because of his immune status.1.Routsi C. Platsouka E. Prekates A. et al.Aspergillus bronchitis causing atelectasis and acute respiratory failure in an immunocompromised patient.Infection. 2001; 29: 243-244Crossref PubMed Scopus (20) Google Scholar, 3.Daly P. Kavanagh K. Pulmonary aspergillosis: clinical presentation, diagnosis and therapy.Br. J. Biomed. Sci. 2001; 58: 197-205PubMed Google Scholar, 4.Kemper C.A. Hostetler J.S. Follansbee S.E. et al.Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS.Clin. Infect Dis. 1993; 17: 344-352Crossref PubMed Scopus (106) Google Scholar His condition improved following stenting, but his symptoms returned at day five. His condition subsequently improved following combination therapy with transbronchial debridement, lavage, fog inhalation with amphotericin B, intravenous use of amphotericin B and liposomal amphotericin B, and intravenous and oral use of itraconazole. This indicates that simply using local debridement or antifungal agents is inadequate for curing obstructing bronchial aspergillosis. The patient responded well to the combination therapy. This work was supported by the fund of Changzheng Hospital Science and Technology Investigation. Presented in part at the 6th Conference of China Mycology in Beijing in September 2003. Conflict of interest: No conflicting interest declared.